ArticleBMC geriatrics2025
An analysis of curative care expenditure for Parkinson's disease under different comorbidity conditions: an empirical study based on China.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Access, stigma and community engagement: implementation strategies for rural and underserved populations.Journal of neural transmission (Vienna, Austria : 1996) · 2026Review
- Curative care expenditure across different comorbidity states of chronic hepatitis B: a prevalence study in Sichuan Province, China.BMJ open · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThis study aims to evaluate the curative care expenditure (CCE) of Parkinson's disease (PD) under different comorbidity conditions to provide a reference basis for formulating health policies for PD.
methodsThis study used a multi-stage stratified random sampling method to investigate 37,604 PD patients in 1,600 medical institutions in Sichuan, China, in 2019. Based on the System of Health Accounts 2011 (SHA2011), the scale of the CCE, financing schemes, institutional flows, and beneficiary groups of PD under different comorbidity conditions were calculated. Multiple linear regression model was used to analyze the factors influencing the hospitalization expenditure.
resultsIn 2019, the total CCE for PD in Sichuan was US$36.29 million, accounting for 0.11% of the province's total disease CCE and 0.005% of its gross domestic product (GDP) that year. Household out-of-pocket (OOP) payments (68.98% for outpatients and 42.26% for inpatients) and public financing schemes (30.69% for outpatients and 52.28% for inpatients) were the main sources of financing CCE. More than 80% of the CCE went to general hospitals, while less than 2% went to primary health-care institutions. As the comorbidity index increased, the CCE for PD exhibited an aging trend, with the low-, medium-, and high-comorbidity groups mainly concentrated in those in their fifties, those aged 60-79, and those over 80, respectively. The multiple linear regression analysis showed that the top three factors affecting hospitalization expenditure were the length of stay, surgery and institution level.
conclusionsThe CCE for PD is high, and individuals and families are the main bearers of health expenditures. It is recommended to optimize medical insurance policies, increase outpatient insurance coverage, and gradually increase the level of insurance benefits. Furthermore, it is necessary to explore multi-party collaboration to establish a diversified and multi-level medical security system for PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.